ducovest

GMF:ARCA-SPDR S&P Emerging Asia Pacific (USD)

ETF | Pacific/Asia ex-Japan Stk | NYSE Arca

Last Closing

USD 103.25

Change

-0.22 (-0.21)%

Market Cap

USD 0.32B

Volume

8.04K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index based upon the emerging markets of the Asia Pacific region. In seeking to track the performance of the S&P Asia Pacific Emerging BMI Index (the "index"), the fund employs a sampling strategy, which means that the fund is not required to purchase all of the securities represented in the index. The index is a market capitalization weighted index designed to define and measure the investable universe of publicly traded companies domiciled in emerging Asian Pacific markets. The fund is non-diversified.

Company Website : www.spdrs.com

Currency: USD

Country : USA

Inception Date: 19/03/2007

Primary Benchmark: S&P Asia Pacific Emerging BMI NR USD

Primary Index: MSCI ACWI Ex USA NR USD

Gross Expense Ratio: 0.53%

Management Expense Ratio: 0.49 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
BETRF BetterLife Pharma Inc 1.89 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Pacific/Asia ex-Japan Stk

Symbol Name Mer Price(Change) Market Cap
EPP iShares MSCI Pacific ex Japan .. 0.48 %

+0.29 (+0.69%)

 USD 1.83B
HAUZ Xtrackers International Real E.. 0.28 %

+0.23 (+1.12%)

 USD 0.67B
ASEA Global X FTSE Southeast Asia E.. 0.65 %

-0.15 (-0.98%)

 USD 0.04B
FLAX Franklin FTSE Asia ex Japan ET.. 0.19 %

+0.22 (+0.99%)

 USD 0.03B

ETFs Containing GMF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pacific/Asia ex-Japan Stk) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.16% 100% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.16% 100% F 41% F
Trailing 12 Months  
Capital Gain 3.44% 80% B- 38% F
Dividend Return 2.78% 60% D- 40% F
Total Return 6.22% 100% F 35% F
Trailing 5 Years  
Capital Gain 4.47% 100% F 48% F
Dividend Return 11.44% 50% F 44% F
Total Return 15.91% 100% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain 2.64% 100% F 52% F
Dividend Return 4.67% 100% F 51% F
Total Return 2.03% 40% F 48% F
Risk Return Profile  
Volatility (Standard Deviation) 20.87% 40% F 55% F
Risk Adjusted Return 22.38% 100% F 48% F
Market Capitalization 0.32B 60% D- 39% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.